Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...
CAMBRIDGE, England & STEVENAGE, England--(BUSINESS WIRE)--Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and ...
Automation will help the cell therapy sector reduce the number of expert staff needed to manufacture these lifesaving therapies, thereby making them more affordable. A team, led by researchers at the ...
The market is projected to surpass $16 billion by 2033, reflecting its rapid transition from research labs into clinical applications such as oncology and prenatal testing. Yet despite this momentum, ...
MONTREAL, May 5, 2025 /PRNewswire/ - Vention, creator of the world's only full-stack software and hardware automation platform, today announced the commercial availability of its powerful ...
A new technical paper titled “Novel Transformer Model Based Clustering Method for Standard Cell Design Automation” was published by researchers at Nvidia. “Standard cells are essential components of ...
Methods Machine Tools Med Cell is a compact, fully integrated design thats easy to configure for producing precision components in a range of materials The Med Cell is served by a high-speed, six-axis ...
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback